4//SEC Filing
Kim Lorence H. 4
Accession 0001610717-25-000271
CIK 0001628171other
Filed
Jun 29, 8:00 PM ET
Accepted
Jun 30, 4:25 PM ET
Size
6.7 KB
Accession
0001610717-25-000271
Insider Transaction Report
Form 4
Kim Lorence H.
Director
Transactions
- Award
Common Stock
2025-06-26+3,142→ 73,090 total - Award
Stock Option (Right to Buy)
2025-06-26+11,574→ 11,574 totalExercise: $37.48Exp: 2035-06-26→ Common Stock (11,574 underlying)
Footnotes (2)
- [F1]Includes 4,017 Restricted Stock Units.
- [F2]Shares subject to the Option shall vest in full on the earlier of (i) the first anniversary of June 26, 2025 or (ii) immediately prior to the Annual Meeting following the date of grant subject to the Reporting Person remaining a Service Provider (as defined in the 2020 Plan) through the vesting date.
Documents
Issuer
Revolution Medicines, Inc.
CIK 0001628171
Entity typeother
Related Parties
1- filerCIK 0001643746
Filing Metadata
- Form type
- 4
- Filed
- Jun 29, 8:00 PM ET
- Accepted
- Jun 30, 4:25 PM ET
- Size
- 6.7 KB